The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 1 , Pages 21-28.e4 , January 2007

Hemodynamic effects of partial ventricular support in chronic heart failure: Results of simulation validated with in vivo data

  • Deborah Morley, PhD

      Affiliations

    • Department of Clinical Affairs, CircuLite, Inc, Hackensack, NJ
    • Corresponding Author InformationAddress for reprints: Deborah Morley, PhD, CircuLite, Inc, Clinical and Regulatory, 401 Hackensack Ave, Hackensack, NJ 07601
  • ,
  • Kenneth Litwak, DVM, PhD

      Affiliations

    • Department of Surgery, University of Louisville, Louisville, Kentucky
  • ,
  • Paul Ferber, BS

      Affiliations

    • Center for New Media Teaching and Learning, Columbia University, New York, NY
  • ,
  • Paul Spence, MD

      Affiliations

    • Louisville, Ky
  • ,
  • Robert Dowling, MD

      Affiliations

    • Department of Surgery, University of Louisville, Louisville, Kentucky
  • ,
  • Bart Meyns, MD, PhD

      Affiliations

    • Department of Surgery, University of Leuven, Leuven, Belgium
  • ,
  • Bartley Griffith, MD

      Affiliations

    • Department of Surgery, University of Maryland, Baltimore, Maryland
  • ,
  • Daniel Burkhoff, MD, PhD

      Affiliations

    • Center for New Media Teaching and Learning, Columbia University, New York, NY
    • Cardiovascular Research Foundation, Orangeburg, NY

Received 22 November 2005 ,Revised 9 June 2006 ,Accepted 7 July 2006.

  • Image Result

    A, Pressure-volume relationships for normal and varying degrees of heart failure conditions. LV, Left ventricular; CHF, congestive heart failure. B, Pressure and flow tracings for normal and varying d

    A, Pressure-volume relationships for normal and varying degrees of heart failure conditions. LV, Left ventricular; CHF, congestive heart failure. B, Pressure and flow tracings for normal and varying degrees of heart failure. Extreme left shows tracing in normal condition, with increasing degrees of failure progressing from left to right. MVF, Mitral valve flow; AoF, aortic flow.

  • Image Result
    A, Pressure-volume loop at baseline heart failure state (solid line), with pump on (simulation 26,000 rpm, 3 L/min flow) and withdrawing blood from the left atrium (dashed line), and withdrawing blood

    A, Pressure-volume loop at baseline heart failure state (solid line), with pump on (simulation 26,000 rpm, 3 L/min flow) and withdrawing blood from the left atrium (dashed line), and withdrawing blood from the left ventricle (dotted line). LVD, left ventricular dysfunction; LA, left atrium; Ao, aorta; LVAD, left ventricular assist device; LVP, left ventricular pressure; LVV, left ventricular volume. B, Pressure and flow tracings with the pump off and on (approximately 26,000 rpm, 3 L/min flow) in left atrial (LA)–aortic (Ao) and left ventricular (LV)–aortic bypass configuration. LVAD, Left ventricular assist device; MVF, Mitral valve flow; AoF, aortic flow.

  • Image Result
    A, Total cardiac output (CO) as a function of ventricular assist device flow. The difference in the slope of the relationship for mild and severe heart failure indicates that the effect of partial ven

    A, Total cardiac output (CO) as a function of ventricular assist device flow. The difference in the slope of the relationship for mild and severe heart failure indicates that the effect of partial ventricular assist device support on cardiac output is greater when the heart is less dilated and weak. CHF, congestive heart failure; LVAD, left ventricular assist device. B, Left ventricular end-diastolic pressure (LV EDP) as a function of ventricular assist device flow, further substantiating that this model predicts any degree of partial support to be hemodynamically more effective in states of mild compared with severe heart failure. CHF, Congestive heart failure; LVAD, left ventricular assist device.

  • Image Result
    A, Effect of patient volume status on ventricular assist device performance during mild and severe heart failure. At each level of heart failure, partial ventricular assist device support increased to

    A, Effect of patient volume status on ventricular assist device performance during mild and severe heart failure. At each level of heart failure, partial ventricular assist device support increased total output by the same amount at any given intrinsic cardiac output value. CO, Cardiac output; LVAD, left ventricular assist device; CHF, congestive heart failure. B, Effect of patient volume status on left ventricular end-diastolic pressure (LV EDP) with ventricular assist device support during mild and severe heart failure. The effect of partial ventricular assist device support on LV EDP was nonlinear, having a greater effect at lower end-diastolic pressures. LVAD, Left ventricular assist device; CHF, congestive heart failure.

  • Image Result
    A, Demonstration of the effects of preload and afterload manipulation to optimize the hemodynamic effectiveness of a partial-support ventricular assist device. LVP, Left ventricular pressure; CHF, con

    A, Demonstration of the effects of preload and afterload manipulation to optimize the hemodynamic effectiveness of a partial-support ventricular assist device. LVP, Left ventricular pressure; CHF, congestive heart failure; LVAD, left ventricular assist device; LVV, left ventricular volume. B, Hemodynamic parameters with varying preload and afterload with and without partial ventricular assist device support. LV EDP, Left ventricular end-diastolic pressure; MAP, mean arterial pressure; CO, cardiac output; CHF, congestive heart failure; LVAD, left ventricular assist device.

  • Image Result
    A, In vivo relationship of pump output and total cardiac output. This relationship approximates the same relationship resulting from the simulation. B, In vivo relationship between pump output and lef

    A, In vivo relationship of pump output and total cardiac output. This relationship approximates the same relationship resulting from the simulation. B, In vivo relationship between pump output and left atrial pressure (LAP). Note the similarity of the in vivo relationship to the simulated relationship.

  • Image Result
    As the severity of disease increases from normal to New York Heart Association class III and IV and ultimately to cardiogenic shock (CGS), the possible maximal cardiac output decreases from that capab

    As the severity of disease increases from normal to New York Heart Association class III and IV and ultimately to cardiogenic shock (CGS), the possible maximal cardiac output decreases from that capable of supporting full exertion to that barely necessary to support life. Partial support fills the gap between patients needing small amounts of hemodynamic support to meaningfully enhance exercise tolerance, such as can be provided by cardiac resynchronization therapy (CRT), and those with severe heart failure who require a device that fully assumes the work of the heart. LVAD, Left ventricular assist device.

  • Image Result
    Electrical analog modeling cardiovascular system.

    Electrical analog modeling cardiovascular system.

  • Image Result
    Pressure-flow characteristics of pump modeled. The gray box demarcates clinically relevant operating points for the pump.

    Pressure-flow characteristics of pump modeled. The gray box demarcates clinically relevant operating points for the pump.

 The study was supported by a grant from CircuLite, Inc. Deborah Morley reports CircuLite employment and stock options. Kenneth Litwak reports CircuLite consulting fees. Paul Ferber Reports Atria Medical, CircuLite, Dupont, and Transoma consulting fees. Paul Spence reports CircuLite consulting fees, equity, and patents. Robert Dowling reports CircuLite consulting fees. Bart Meyns reports Abiomed lecture fees, CircuLite consulting fees and equity, and grant support from Abiomed and CircuLite. Bartley Griffith reports WorldHeart consultant fees. Daniel Burkhoff reports Accelerated Technologies and Impulse Dynamics consulting fees; Abiomed, CircuLite, and Impulse Dynamics equity; and grant support from CircuLite. All of the companies listed have direct or indirect commercial interests in implantable cardiac assist devices.

PII: S0022-5223(06)01572-8

doi: 10.1016/j.jtcvs.2006.07.037

The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 1 , Pages 21-28.e4 , January 2007